Cyclis Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Cyclis Pharmaceuticals General Information
Description
Developer of small molecule drugs for the treatment of cancer. The company specializes in discovering and developing novel small molecule drugs designed to correct cellular checkpoint and apoptotic defects common in cancer cells with the help of an activated checkpoint therapy, enabling clients to receive higher efficacy and reduced toxicity over traditional cancer treatments.
Contact Information
Website
www.cyclispharma.comCorporate Office
- 333 Providence Highway
- Norwood, MA 02062
- United States
Corporate Office
- 333 Providence Highway
- Norwood, MA 02062
- United States
Cyclis Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyclis Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cyclis Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cyclis Pharmaceuticals FAQs
-
When was Cyclis Pharmaceuticals founded?
Cyclis Pharmaceuticals was founded in 2001.
-
Where is Cyclis Pharmaceuticals headquartered?
Cyclis Pharmaceuticals is headquartered in Norwood, MA.
-
What industry is Cyclis Pharmaceuticals in?
Cyclis Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Cyclis Pharmaceuticals a private or public company?
Cyclis Pharmaceuticals is a Private company.
-
What is the current valuation of Cyclis Pharmaceuticals?
The current valuation of Cyclis Pharmaceuticals is .
-
What is Cyclis Pharmaceuticals’s current revenue?
The current revenue for Cyclis Pharmaceuticals is .
-
Who are Cyclis Pharmaceuticals’s investors?
Ampersand Capital Partners has invested in Cyclis Pharmaceuticals.
-
When was Cyclis Pharmaceuticals acquired?
Cyclis Pharmaceuticals was acquired on 08-Sep-2003.
-
Who acquired Cyclis Pharmaceuticals?
Cyclis Pharmaceuticals was acquired by ArQule.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
